| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |